α-Synuclein Expression Modulates Microglial Activation Phenotype
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Recent Parkinson's disease research has focused on understanding the function of the cytosolic protein, α-synuclein, and its contribution to disease mechanisms. Within neurons, α-synuclein is hypothesized to have a role in regulating synaptic plasticity, vesicle release, and trafficking. In contrast, glial-expressed α-synuclein remains poorly described. Here, we examine the consequence of a loss of α-synuclein expression on microglial activation. Using a postnatal brain-derived culture system, we defined the phenotype of microglia from wild-type and knock-out α-synuclein mice (Scna−/−).Scna−/−microglia displayed a basally increased reactive phenotype compared with the wild-type cells and an exacerbated reactive phenotype after stimulation. They also exhibited dramatic morphologic differences compared with wild-type, presenting as large, ramified cells filled with vacuole-like structures. This corresponded with increased protein levels of activation markers, CD68 and β1 integrin, in the Scna−/−cells. More importantly,Scna−/−microglia, after stimulation, secreted elevated levels of proinflammatory cytokines, TNFα (tumor necrosis factor α) and IL-6 (interleukin-6), compared with wild type. However, despite the reactive phenotype,Scna−/−cells had impaired phagocytic ability. We demonstrate for the first time that α-synuclein plays a critical role in modulating microglial activation state. We suggest that altered microglial α-synuclein expression will affect their phenotype as has already been demonstrated in neurons. This has direct ramifications for the contribution of microglia to the pathophysiology of disease, particularly in familial cases linked to altered α-synuclein expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 2×
“It is now appreciated that a spectrum of microglial activation states exist (Mantovani et al., 2002; Gordon, 2003).”
Backgroundα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · cited 1×
“Overexpression and mutations in -synuclein are associated with early-onset Parkinson’s disease (PD) (Polymeropoulos et al., 1997; Kruger et al., 1998; Singleton et al., 2003).”
BackgroundAlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Mice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265 · cited 3×
“Although microglial activation in vivo correlates with fibrillar -synuclein deposition and that fibrillar -synuclein is capable of activating microglia in vitro (Croisier et al., 2005; Zhang et al., 2005), our work suggests that altered or mutant microglial -synuclein expression may result in a direct contribution by…”
BackgroundCabin, D. E., Shimazu, K., Murphy, D., Cole, N. B., Gottschalk, W., McIlwain, K. L., Orrison, B., Chen, A., Ellis, C. E., Paylor, R., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-08797.2002 · Cited by 865
Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
Peng, X. M., Tehranian, R., Dietrich, P., Stefanis, L., & Perez, R. G. (2005) · Journal of Cell Science · doi:10.1242/jcs.02481 · Cited by 249 · cited 2×
“-Synuclein binds a variety of proteins (Jenco et al., 1998; Peng et al., 2005) and lipid vesicles (Cole et al.”
BackgroundExpression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease
Frohman, E. M., Frohman, T. C., Gupta, S., de Fougerolles, A., & van den Noort, S. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90202-i · Cited by 120 · cited 2×
“…of proteins, including cell adhesion molecules, such as ICAM-1 (intercellular adhesion molecule 1) and 1 integrin, cytokines, such as TNF and IL-6, and costimulatory molecules, such as MHC II (major histocompatibility complex II) (Frohman et al., 1991; Boka et al., 1994; McGeer et al., 1988, 2001).”
BackgroundAmyloid precursor protein mediates proinflammatory activation of monocytic lineage cells
Sondag, C. M., & Combs, C. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313747200 · Cited by 56
Self-citationUpregulation of α‐synuclein by lipopolysaccharide and interleukin‐1 in human macrophages
Tanji, K., Mori, F., Imaizumi, T., Yoshida, H., Matsumiya, T., Tamo, W., Yoshimoto, M., Odagiri, H., Sasaki, M., Takahashi, H., et al. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01385.x · Cited by 55 · cited 1×
“Recent studies in human astrocytes and macrophages have demonstrated an increase in -and -synuclein expression, respectively, after stimulation with lipopolysaccharide (LPS) and interleukin-1 (IL-1), suggesting a role for -synuclein in the inflammatory process (Tanji et al., 2001, 2002).”
Background
Cited by
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446
“…underlie its inhibitory effect on neuronal transmission (Darios et al. 2010), and that alterations in levels of key enzymes in lipid signaling, such as PLD2 and PLA2, may underlie the phenotype in SNCA null microglia, which are overreactive but lack phagocytic potential (Austin et al. 2006, 2011).”
BackgroundOxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878
“Moreover, in α-syn KO mice, microglia secreted higher levels of proinflammatory cytokines, TNF alpha and IL-6 (interleukin6) compared to WT mice (Austin et al., 2006).”
BackgroundGlial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
Metadata
- Authors
- Austin, S. A., Floden, A. M., Murphy, E. J., & Combs, C. K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2006-10-11
- Volume
- 26
- Issue
- 41
- Pages
- 10558-10563
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2061471792
- Cited by
- 142
- References
- 13
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.